不同算法及截断值在子痫前期早孕期筛查中的效能。
Effectiveness of Different Algorithms and Cut-off Value in Preeclampsia First Trimester Screening.
机构信息
Department of Gynecology and Obstetrics, Pomeranian Medical University, 70-111 Szczecin, Poland.
Department of Obstetrics and Gynecology in Ruda Slaska, Medical University of Silesia, 41-703 Ruda Slaska, Poland.
出版信息
J Pregnancy. 2022 Apr 8;2022:6414857. doi: 10.1155/2022/6414857. eCollection 2022.
Abstract
RESULTS
For the cut-off point >1 : 150, 86 women at an increased risk of eo-PE using algorithm 1 were identified. Of these 86 patients, 83 (96%) were identified using algorithm 2, 62 (72%) using algorithm 3, and 60 (69%) using algorithm 4. In addition, it was demonstrated that between 21% and 29% of women at a low risk of eo-PE could be given acetylsalicylic acid if a screening test was used that did not account for PlGF.
CONCLUSIONS
In order to provide the highest level of health care to pregnant women, it is extremely important that full screening for eo-PE should be ensured. The cheapest algorithm based only on MAP and UtPI resulted in our patients being unnecessarily exposed to complications.
摘要
结果
对于截断值>1:150，使用算法 1 确定了 86 名发生 eo-PE 风险增加的女性。在这 86 名患者中，83 名（96%）使用算法 2 识别，62 名（72%）使用算法 3，60 名（69%）使用算法 4。此外，研究表明，如果使用不考虑 PlGF 的筛查试验，可将 21%至 29%的 eo-PE 低风险女性给予乙酰水杨酸。
结论
为了为孕妇提供最高水平的医疗保健，确保充分筛查 eo-PE 极其重要。基于仅 MAP 和 UtPI 的最便宜算法导致我们的患者不必要地面临并发症。
相似文献
1
Effectiveness of Different Algorithms and Cut-off Value in Preeclampsia First Trimester Screening.
J Pregnancy. 2022 Apr 8;2022:6414857. doi: 10.1155/2022/6414857. eCollection 2022.
2
Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
Ultrasound Obstet Gynecol. 2020 Sep;56(3):400-407. doi: 10.1002/uog.22093. Epub 2020 Aug 5.
3
ASPRE trial: performance of screening for preterm pre-eclampsia.
Ultrasound Obstet Gynecol. 2017 Oct;50(4):492-495. doi: 10.1002/uog.18816. Epub 2017 Aug 24.
4
Routine first-trimester combined screening for pre-eclampsia: pregnancy-associated plasma protein-A or placental growth factor?
Ultrasound Obstet Gynecol. 2021 Oct;58(4):540-545. doi: 10.1002/uog.23669. Epub 2021 Sep 13.
5
Developing a new algorithm for first and second trimester preeclampsia screening in twin pregnancies.
Hypertens Pregnancy. 2017 Feb;36(1):108-115. doi: 10.1080/10641955.2016.1242605. Epub 2016 Nov 11.
6
Diagnostic accuracy of first-trimester combined screening for early-onset and preterm pre-eclampsia at 8-10 compared with 11-13 weeks' gestation.
Ultrasound Obstet Gynecol. 2021 Jan;57(1):84-90. doi: 10.1002/uog.22071.
7
Performance of Fetal Medicine Foundation algorithm for first trimester preeclampsia screening in an indigenous south Asian population.
BMC Pregnancy Childbirth. 2021 Dec 4;21(1):805. doi: 10.1186/s12884-021-04283-6.
8
Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation.
Am J Obstet Gynecol. 2016 May;214(5):619.e1-619.e17. doi: 10.1016/j.ajog.2015.11.016. Epub 2015 Nov 25.
9
Importance of Timing First-Trimester Placental Growth Factor and Use of Serial First-Trimester Placental Growth Factor Measurements in Screening for Preeclampsia.
Fetal Diagn Ther. 2017;42(2):111-116. doi: 10.1159/000455946. Epub 2017 Feb 16.
10
Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestation.
Am J Obstet Gynecol. 2016 Jul;215(1):87.e1-87.e17. doi: 10.1016/j.ajog.2016.02.016. Epub 2016 Feb 12.
引用本文的文献
1
Non-linear dose-response relationship between uterine artery pulsatility index and risk of preeclampsia in early pregnancy: A secondary analysis based on a nested cohort study.
PLoS One. 2025 Jan 16;20(1):e0317625. doi: 10.1371/journal.pone.0317625. eCollection 2025.
2
Comparison of Pre-eclampsia Screening Algorithms in the First Trimester of Pregnancy Being Used in Thai Nguyen Province.
Cureus. 2024 Apr 27;16(4):e59133. doi: 10.7759/cureus.59133. eCollection 2024 Apr.
3
Could signal peptide complement C1r/C1s, Uegf, and Bmp1, and epidermal growth factor-containing protein 1 be a therapeutic target in the pathogenesis of preeclampsia?
Rev Assoc Med Bras (1992). 2024 Mar 4;70(3):e20231027. doi: 10.1590/1806-9282.20231027. eCollection 2024.
4
Low-Dose Aspirin after ASPRE-More Questions Than Answers? Current International Approach after PE Screening in the First Trimester.
Biomedicines. 2023 May 23;11(6):1495. doi: 10.3390/biomedicines11061495.
本文引用的文献
1
Cut-off values for Gaussian first-trimester screening for early-onset preeclampsia with maternal history, biochemical markers and uterine artery Doppler.
J Gynecol Obstet Hum Reprod. 2021 Jan;50(1):101827. doi: 10.1016/j.jogoh.2020.101827. Epub 2020 Jun 5.
2
Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
Ultrasound Obstet Gynecol. 2020 Sep;56(3):400-407. doi: 10.1002/uog.22093. Epub 2020 Aug 5.
3
The need for implementation of first trimester screening for preeclampsia and fetal growth restriction in low resource settings.
J Matern Fetal Neonatal Med. 2021 Dec;34(24):4082-4089. doi: 10.1080/14767058.2019.1704246. Epub 2020 Jan 3.
4
Strategies for Prescribing Aspirin to Prevent Preeclampsia: A Cost-Effectiveness Analysis.
Obstet Gynecol. 2020 Jan;135(1):217. doi: 10.1097/AOG.0000000000003631.
5
Strategies for Prescribing Aspirin to Prevent Preeclampsia: A Cost-Effectiveness Analysis.
Obstet Gynecol. 2019 Sep;134(3):537-544. doi: 10.1097/AOG.0000000000003413.
6
The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Int J Gynaecol Obstet. 2019 May;145 Suppl 1(Suppl 1):1-33. doi: 10.1002/ijgo.12802.
7
Assessment of NICE and USPSTF guidelines for identifying women at high risk of pre-eclampsia for tailoring aspirin prophylaxis in pregnancy: An individual participant data meta-analysis.
Eur J Obstet Gynecol Reprod Biol. 2018 Oct;229:159-166. doi: 10.1016/j.ejogrb.2018.08.587. Epub 2018 Sep 2.
8
Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation.
Ultrasound Obstet Gynecol. 2018 Aug;52(2):186-195. doi: 10.1002/uog.19112. Epub 2018 Jul 11.
9
Cost-effectiveness of first-trimester screening with early preventative use of aspirin in women at high risk of early-onset pre-eclampsia.
Ultrasound Obstet Gynecol. 2019 Feb;53(2):239-244. doi: 10.1002/uog.19076.
10
Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit.
Am J Obstet Gynecol. 2018 Jun;218(6):612.e1-612.e6. doi: 10.1016/j.ajog.2018.02.014. Epub 2018 Mar 2.
Zotero 插件